ACCCBUZZ BLOG

As pancreatic cancer awareness month approaches, Let's Win Pancreatic Cancer shares a series of inspiring patient stories.

ACCC recognizes breast cancer awareness month.

Learn about key barriers in care coordination and therapy options for patients with AML who are not eligible for transplant and how providers can address them.

Josh Hendricks BSN, OCN, operations manager for Corewell Health West, discusses the importance of humility as a leader.

ACCC president Olalekan Ajayi, PharmD, MBA, shared the association’s key priorities for impacting cancer care in the United States with the President’s Cancer Panel.

Highlights from the third and final day of #ACCCNOC.

Highlights from a day of learning at day 2 of #ACCCNOC.

Key takeaways from day 1 of #ACCCNOC.

Insight from 2 ACCC members on the implementation of the Improving Care Coordination Model.

Let’s Win Pancreatic Cancer provides a road map of resources to help newly diagnosed patients with pancreatic cancer obtain the resources they need throughout their care journey.

The Centers for Medicare and Medicaid Services has recently proposed reimbursement for Principal Illness Navigation services under Medicare to help patients navigate treatment for serious illnesses such as cancer.

This cancer program adapted the University of Washington’s Collaborative Care model to embed counseling services into oncology and palliative care across six clinic locations. This model allows patients to receive counseling for depression, anxiety, or other psycho-social concerns while in active treatment and survivorship, eliminating many barriers to care.

Learn how the creation of the first advanced practice radiation therapist (APRT) role in the United States established a new model of inpatient care, elevating the radiation therapy skill set and allowing for intervention at key points along the radiation oncology care pathway.

Through a series of education projects, ACCC is committed to providing the resources the multidisciplinary cancer care team will need to navigate the complex precision medicine landscape and deliver next generation cancer care.

As immune checkpoint inhibitors have become the standard of care for eligible patients with NSCLC, frequent monitoring of irAEs as well as provider and patient education on the signs and symptoms of pneumonitis can ensure improved clinical outcomes for patients.

In the era of personalized medicine, biomarker testing is a tool the oncology workforce can and should leverage to deliver next generation cancer care.

Oncology Hematology Care, Inc. launched a one-year quality improvement project to implement and standardize comprehensive biomarker testing in patients with metastatic non-small cell lung cancer.

St. Elizabeth Cancer Center launched a comprehensive program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings.

In her monthly leadership series, Dr Barbara Schmidtman—vice president of cancer health operations at Corewell Health West—offers her perspective on managing conflict in the workplace.

Managing immunotherapy related adverse events (irAEs) requires a team-based effort, with pharmacists playing an integral role in their identification and management within both outpatient and inpatient multidisciplinary teams.

For patients with pancreatic cancer, clinical trials should be considered as a possible treatment option early on, not a last resort when all else fails. The Let's Win team discusses why.

Recognizing the effects of SDOH on patients and providers is key as studies show they can impact as much as 80% to 90% of health-related outcomes.

To explore the current state of psychosocial care in oncology, ACCC, with its partners, AOSW and APOS, with support from BeiGene—held a multistakeholder meeting, ACCC’s Call to Action: Delivery of Psychosocial Care in Oncology Summit.

In the past, patients diagnosed with rare cancer types often faced a bleak prognosis due to limited treatment options. Today, the story is different, as advances in precision medicine and the development of new, targeted therapies continue to permeate the oncology space.

In 2012, August 1 was declared World Lung Cancer Day—11 years later, its significance is as important as ever.

By implementing e-consults for patients experiencing endocrine immune-related adverse events, Duke Cancer Institute improved patient access and reduced healthcare utilization.

ACCC is working with multidisciplinary care teams to assess the impact of SDOH on equitable access to cancer care and clinical trials among minority populations.

In the face of an unprecedented drug shortage, HOPA partnered with ACCC and AVAHO to lead a virtual round table discussing best practices the multidisciplinary cancer care team can use to mitigate its effects.

The survival of pancreatic cancer is 12%, making it one of the deadliest cancers of our time. As a result, understanding the symptoms, risks factors, as well and the benefit of an early diagnosis is key.

In the face of an unprecedented drug shortage, Hematology/Oncology Pharmacy Association (HOPA) partnered with the Association of Community Cancer Centers (ACCC) and Association of VA Hematology/Oncology (AVAHO) to lead a virtual round table aimed at developing practical strategies healthcare organizations around the country can adopt.